Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.

Fotemustine is a new nitrosourea which has shown some efficacy on disseminated malignant melanoma (DMM) (24.2% response rate (RR) among 153 patients i...
327KB Sizes 0 Downloads 0 Views
Download PDF

Recommend Documents

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.
Fotemustine--an advance in the treatment of metastatic malignant melanoma.
Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.
Phase II study of recombinant alpha-interferon in malignant melanoma.
Fotemustine plus dacarbazine for malignant melanoma.
Patellar metastasis from a malignant melanoma.
A phase II investigation of pentostatin in metastatic malignant melanoma.
Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.
Fotemustine and DTIC combination in patients with disseminated malignant melanoma.
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.

Follow Us

Copyright © 2024 D.DOCKSCI.COM. All rights reserved. | Design by w3layouts